BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30609203)

  • 1. Genome-wide DNA methylation profiling shows molecular heterogeneity of anaplastic pleomorphic xanthoastrocytoma.
    Nakamura T; Fukuoka K; Nakano Y; Yamasaki K; Matsushita Y; Yamashita S; Ikeda J; Udaka N; Tanoshima R; Shiba N; Tateishi K; Yamanaka S; Yamamoto T; Hirato J; Ichimura K
    Cancer Sci; 2019 Feb; 110(2):828-832. PubMed ID: 30609203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleomorphic xanthoastrocytoma, anaplastic pleomorphic xanthoastrocytoma, and epithelioid glioblastoma: Case series with clinical characteristics, molecular features and progression relationship.
    Lin Z; Yang R; Zheng H; Li Z; Yi G; Wu Q; Yang C; Huang G
    Clin Neurol Neurosurg; 2022 Oct; 221():107379. PubMed ID: 35932588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.
    Ebrahimi A; Korshunov A; Reifenberger G; Capper D; Felsberg J; Trisolini E; Pollo B; Calatozzolo C; Prinz M; Staszewski O; Schweizer L; Schittenhelm J; Harter PN; Paulus W; Thomas C; Kohlhof-Meinecke P; Seiz-Rosenhagen M; Milde T; Casalini BM; Suwala A; Wefers AK; Reinhardt A; Sievers P; Kramm CM; Etminam N; Unterberg A; Wick W; Herold-Mende C; Sturm D; Pfister SM; Sill M; Jones DTW; Schrimpf D; Reuss DE; Aldape K; Abdullaev Z; Sahm F; von Deimling A; Stichel D
    Acta Neuropathol Commun; 2022 Jan; 10(1):5. PubMed ID: 35012690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and genetic association between epithelioid glioblastoma and pleomorphic xanthoastrocytoma.
    Furuta T; Miyoshi H; Komaki S; Arakawa F; Morioka M; Ohshima K; Nakada M; Sugita Y
    Neuropathology; 2018 Jun; 38(3):218-227. PubMed ID: 29532523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?
    Vaubel R; Zschernack V; Tran QT; Jenkins S; Caron A; Milosevic D; Smadbeck J; Vasmatzis G; Kandels D; Gnekow A; Kramm C; Jenkins R; Kipp BR; Rodriguez FJ; Orr BA; Pietsch T; Giannini C
    Brain Pathol; 2021 Jan; 31(1):20-32. PubMed ID: 32619305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma.
    Lohkamp LN; Schinz M; Gehlhaar C; Guse K; Thomale UW; Vajkoczy P; Heppner FL; Koch A
    PLoS One; 2016; 11(6):e0156422. PubMed ID: 27253461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid glioblastoma arising from pleomorphic xanthoastrocytoma with the BRAF V600E mutation.
    Tanaka S; Nakada M; Nobusawa S; Suzuki SO; Sabit H; Miyashita K; Hayashi Y
    Brain Tumor Pathol; 2014 Jul; 31(3):172-6. PubMed ID: 24894018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
    Phillips JJ; Gong H; Chen K; Joseph NM; van Ziffle J; Bastian BC; Grenert JP; Kline CN; Mueller S; Banerjee A; Nicolaides T; Gupta N; Berger MS; Lee HS; Pekmezci M; Tihan T; Bollen AW; Perry A; Shieh JTC; Solomon DA
    Brain Pathol; 2019 Jan; 29(1):85-96. PubMed ID: 30051528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E, TERT, and IDH2 Mutations in Pleomorphic Xanthoastrocytoma: Observations from a Large Case-Series Study.
    Ma C; Feng R; Chen H; Hameed NUF; Aibaidula A; Song Y; Wu J
    World Neurosurg; 2018 Dec; 120():e1225-e1233. PubMed ID: 30240866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature.
    Sasaki S; Tomomasa R; Nobusawa S; Hirato J; Uchiyama T; Boku E; Miyasaka T; Hirose T; Ohbayashi C
    Brain Tumor Pathol; 2019 Oct; 36(4):169-173. PubMed ID: 31350684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: case report.
    Watanabe N; Ishikawa E; Kohzuki H; Sakamoto N; Zaboronok A; Matsuda M; Shibuya M; Matsumura A
    BMC Neurol; 2020 Jan; 20(1):21. PubMed ID: 31941461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma multiforme versus pleomorphic xanthoastrocytoma with anaplastic features in the pathological diagnosis: a case report.
    Yamada SM; Murakami H; Tomita Y; Nakane M; Shibui S; Takahashi M; Kawamoto M
    Diagn Pathol; 2016 Jul; 11(1):65. PubMed ID: 27449352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma.
    Martínez R; Carmona FJ; Vizoso M; Rohde V; Kirsch M; Schackert G; Ropero S; Paulus W; Barrantes A; Gomez A; Esteller M
    BMC Cancer; 2014 Mar; 14():213. PubMed ID: 24650279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary multicentric anaplastic pleomorphic xanthoastrocytoma with atypical features.
    Montano N; Papacci F; Cioni B; Gaudino S; Della Pepa GM; Conforti G; Di Bonaventura R; Novello M; Lauriola L; Meglio M
    J Clin Neurosci; 2013 Nov; 20(11):1605-8. PubMed ID: 23827171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysis.
    Korshunov A; Chavez L; Sharma T; Ryzhova M; Schrimpf D; Stichel D; Capper D; Sturm D; Kool M; Habel A; Kleinschmidt-DeMasters BK; Rosenblum M; Absalyamova O; Golanov A; Lichter P; Pfister SM; Jones DTW; Perry A; von Deimling A
    Brain Pathol; 2018 Sep; 28(5):656-662. PubMed ID: 28990704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma.
    Tabouret E; Bequet C; Denicolaï E; Barrié M; Nanni I; Metellus P; Dufour H; Chinot O; Figarella-Branger D
    Eur J Surg Oncol; 2015 Dec; 41(12):1685-90. PubMed ID: 26454767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.
    Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T
    World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring DNA Methylation for Prognosis and Analyzing the Tumor Microenvironment in Pleomorphic Xanthoastrocytoma.
    Tang K; Kurland D; Vasudevaraja V; Serrano J; Delorenzo M; Radmanesh A; Thomas C; Spino M; Gardner S; Allen JC; Nicolaides T; Osorio DS; Finlay JL; Boué DR; Snuderl M
    J Neuropathol Exp Neurol; 2020 Aug; 79(8):880-890. PubMed ID: 32594172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.
    Asano K; Miyamoto S; Kubo O; Kikkukawa T; Yagihashi A; Ohkuma H
    Brain Tumor Pathol; 2006 Apr; 23(1):55-63. PubMed ID: 18095120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.